Background: The in vivo relationship of spinal cord lesion features with clinical course and function in multiple sclerosis (MS) is poorly defined.
Introduction
Two long disease duration imaging studies in multiple sclerosis (MS) have shown that spinal cord atrophy is associated with disability, independently from brain atrophy or lesion load. 1, 2 However, neither study investigated the contribution of focal spinal cord lesions or diffuse abnormalities [3] [4] [5] [6] [7] to disease progression.
Focal spinal cord lesions are typically seen on magnetic resonance imaging (MRI) as hyper-intense abnormalities on sagittal T2-weighted images. 3 However, this approach underestimates the number of lesions 8 and axial acquisitions improve detection. 9 A further advantage of axial imaging is that involvement of central grey matter (GM) and white matter (WM) columns by lesions is more clearly determined. [10] [11] [12] In a previous pilot study we used a combination of: axial three-dimensional (3D)-fast-field-echo (FFE) and 3D-phase-sensitive-inversion-recovery (PSIR) scans, on 3T MRI, to record the anatomical location of lesions within the cervical cord. 13 These two sequences combined may therefore be useful to investigate spinal cord imaging abnormalities (both focal and diffuse) that are associated with progression and disability.
In this present study of a moderately large clinical cohort, we investigate the following hypotheses:
(i) More extensive focal lesions, i.e. involving two or more WM columns, occur more frequently in progressive than non-progressive MS. (ii) Extension of focal lesions to GM is more common in progressive MS. (iii) Diffuse abnormalities occur more frequently in progressive MS. (iv) The location of focal cord lesions will affect the association seen with disability -with motor disability being particularly related to lateral column involvement.
Methods

Participants
We recruited people with clinically isolated syndrome (CIS), or MS; 14 subgroups were classified using published criteria. 15 Recruitment was performed without reference to earlier spinal cord imaging findings. None of the participants had a relapse or received corticosteroids within a month prior to participation. Disability was recorded using the Expanded Disability Status Scale (EDSS). 16 This study was approved by the national research ethics service committee and informed written consent was obtained from all participants.
MRI protocol
The 3T MRI protocol for this study was as previously described 13 (provided in full in a supplementary file). Briefly, two 3D-axial sequences were acquired in the upper cervical cord centred at C2/C3: FFE and PSIR, with 0.5 × 0.5 mm 2 in-plane resolution, as well as a sagittal PD/T2 scan of the cervical cord for orientation of the axial slices. In addition a proton-density (PD)/T2 brain scan was acquired for identification of brain lesions.
Image analysis
Using the sagittal image for orientation of axial slices, lesions were first recorded on the slice-matched 3D-FFE and 3D-PSIR images by an experienced reader (HK) using the classification system described below, with subsequent and final confirmation of the presence and classification of all lesions being performed by a second reader, who was an experienced neuroradiologist (KM). 13 Lesions were analysed on all 10 5 mm thick axial slices. Both readers were blinded to the clinical status of the cases being reviewed. Images degraded by artefacts were excluded from analysis.
Focal lesions. We defined focal lesions as abnormal areas of clearly increased signal intensity on the 3D-FFE image and decreased signal intensity on 3D-PSIR image and a clearly demarcated border from the surrounding tissue. Focal lesions were recorded only when they were clearly visible on both scans. Focal lesions were always evident in WM, i.e. they had higher signal on 3D-FFE and lower signal on 3D-PSIR with respect to adjacent WM. While it was possible to identify lesions that extended to the GM, it was not possible to determine their extent or location within GM as lesion signal intensity was generally similar to that of normal cord GM on both sequences.
Focal lesions were classified based on the number of WM columns involved. The column that was maximally covered (in many cases entirely) by a lesion was recorded (in comparison to partial coverage of other columns) and if extension into one or more additional columns was seen (e.g. a lateral column lesion extending into the posterior column), this was also noted.
The classification system devised for lesions is shown in Table 1 . Lesions involving a single column were either confined to WM only (type I -demonstrated in Figure 1 ; in these lesions normal-appearing cord WM was visible between the lesion and GM), or extended to the GM (type II - Figure 2 ). When focal lesions involved two (type III - Figure 3 ) or more (type IV - Figure 4 ) columns, they invariably extended to the GM adjacent to the affected columns, i.e. no lesions involved two or more columns without extending to GM. For lesions that covered multiple slices of the image, their extent was classified from the slice with maximal involvement.
Diffuse abnormalities. These were defined as abnormal areas of intermediate signal intensity, between that of focal lesions and normal-appearing spinal cord ( Figure 5 ). Diffuse abnormalities also lacked a welldemarcated border from adjacent normal-appearing cord. These were recorded on the 3D-FFE scan, where they were visible as an intermediate hyper-intense abnormality relative to the normal-appearing cord. Diffuse abnormalities were often not seen on the 3D-PSIR scan, or if they were, they were poorly defined areas of subtle hypo-intensity relative to normal-appearing cord.
Diffuse abnormalities were recorded, when seen, as present or absent. An anatomical classification system based on spinal cord columnar involvement -as undertaken for focal lesions -could not be implemented due to the absence of a clearly defined border demarcating their termination. To test whether more extensive (types III and IV) focal lesions, extension to GM, and diffuse abnormalities would be seen more frequently in progressive MS, we compared these lesion characteristics between groups using logistic regression, with the lesional element being compared (lesion extent, extension to GM, and diffuse abnormalities) as the binary dependent variable. Clinical subgroup indicators were entered as predictors in each model and adjustment was made for age, gender and disease duration. Separate adjustment was performed so that age and disease duration were not in the model simultaneously, since across patient groups disease duration will necessarily vary substantially in patients of the same age. Where patients did not have a particular lesion characteristic (e.g. diffuse abnormalities), an exact chi-square test was used. To minimise the number of comparisons, only the following four were performed: RRMS vs. each of the three other groups (CIS, PPMS and SPMS), and PPMS vs. SPMS.
Statistical analysis
Due to the exploratory nature of the study, no adjustment for multiple comparisons was performed. 18 
Lesion features: investigation for independent associations with physical disability. A multiple linear regression model was constructed with EDSS as response variable on the lesion predictors listed in the
Results
Demographics of clinical subgroups (Table 2)
We recruited 120 people: 25 CIS, 35 RRMS, 30 SPMS and 30 PPMS. Three participants' scans were excluded due to motion: CIS (n = 1), RRMS (n = 1) and SPMS (n = 1). Using the T2-weighted brain scan, criteria for dissemination in space was fulfilled in 15 cases of the CIS cohort; it was not possible to investigate for dissemination in time, with a single time point non-contrast enhanced scan. 14 
Number of focal spinal cord lesions by type (I-IV) and location (Table 3)
Lesion numbers in each category (type I-IV) are summarised in Table 3 . We identified 354 focal spinal cord lesions in total. Although similar numbers of type I lesions (involving a single WM column) were seen in all subgroups of MS, a higher number of focal lesions that involved two columns (type III) were seen in SPMS (n = 22) compared to either RRMS (n = 16) or CIS (n = 2). There were also a higher number of type IV lesions (involving three or more WM columns) in progressive MS: SPMS (n = 8), PPMS (n = 5), RRMS (n = 1) and CIS (n = 0).
Focal lesions involved the lateral and posterior columns (75% and 38% of lesions, respectively) more frequently than the anterior column (6%). Extension to the GM was seen in 67% of the lesions.
Lesion characteristics by MS subgroup (Table 4)
The proportion of people with one or more focal spinal cord lesions increased in the order: CIS (42%), RRMS (85%), PPMS (97%) and SPMS (100%). The mean of the total number of lesions per patient similarly increased in the order: CIS (mean 0.8), RRMS (2.8), PPMS (3.5) and SPMS (4.7). This increase was approximately linear with a significant increase of 1.2 (95% confidence interval (CI) 0.9, 1.6; p < 0.001) lesions per MS subgroup. Adjustment for age, gender and disease duration did not affect the results. The mean, median and range per participant of the number of cord lesions in each subgroup are shown in Table 5 .
The proportion of individuals with more-extensive lesions (type III or IV) was significantly higher in RRMS vs. CIS (odds ratio (OR) 6.8, 95% CI 1.4, 33.9; p = 0.019), SPMS vs. RRMS (OR 3.1, 95% CI (17) Data represent mean ± standard deviation. a The CIS cohort: optic neuritis (n = 21), partial myelitis (n = 2), multifocal CIS (n = 1; optic neuritis with a brainstem syndrome) and hemispheric presentation (n = 1; unilateral hand weakness due to a motor cortex lesion). b Disease-modifying drugs in RRMS cohort: β-interferon (n = 13), natalizumab (n = 5), and glatiramer acetate (n = 1). c SPMS cohort: β-interferon (n = 5). MS: multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; PPMS: primary progressive multiple sclerosis; SPMS: secondary progressive multiple sclerosis; CIS: clinically isolated syndrome; EDSS: Expanded Disability Status Scale. The cumulative numbers of lesions with specified white matter column involvement exceeds the total number of lesions, since some lesions seen involved more than one column, e.g. extension into the lateral and posterior column by the same lesion. MS: multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; PPMS: primary progressive multiple sclerosis; SPMS: secondary progressive multiple sclerosis; CIS: clinically isolated syndrome.
1.1, 8.7; p = 0.033) and in SPMS vs. PPMS (OR 3.8, 95% CI 1.3, 11.2; p = 0.015). No differences were seen between PPMS vs. RRMS (OR 3.2, 95% CI 0.79, 13.3; p = 0.104). These significant group differences remained after adjusting for age, gender or disease duration.
The proportion of individuals with lesions extending to the GM (type II-IV) was also greater in RRMS vs. Diffuse abnormalities were present in over half of PPMS (57%) and SPMS (55%) patients but in only 18% of RRMS and none of CIS (p = 0.037 for RRMS vs. CIS, exact chi-square test). The OR for having diffuse abnormalities was higher in PPMS vs. RRMS at 6.1 (CI 2.0, 19.1; p = 0.002) and for SPMS vs. RRMS, 5.7 (95% CI 1.8, 18.1; p = 0.003). These significant differences remained after adjustment for age, gender or disease duration.
Independent associations between EDSS and spinal cord lesion characteristics
The best independent predictors of EDSS were found to be the number of an individual's lesions which involved a lateral column and extended to GM (p = 0.0007), and the patient's most extensive lesion (i.e. the lesion that covered the greatest number of columns in that patient, entered as a single term rather than as a categorical variable, p = 0.045), in a model also containing age at scan (predicted 0.06 increase in mean EDSS per year of age, p < 0.001), gender (predicted 0.60 higher mean EDSS in men compared to women, p = 0.032) and disease duration (predicted 0.07 increase in mean EDSS per year duration, p = 0.001).
In this model, compared to individuals with no lesions that involved a lateral column and extended to GM, having one, two and three or more such lesions Three peoples' scans were excluded from analysis due to motion artefacts on images: clinically isolated syndrome (n = 1), RRMS (n = 1) and SPMS (n = 1). MS: multiple sclerosis; RRMS: relapsing-remitting multiple sclerosis; PPMS: primary progressive multiple sclerosis; SPMS: secondary progressive multiple sclerosis; CIS: clinically isolated syndrome. predicted respectively 0.8 (95% CI −0.26,1.77; p = 0.143)), 0.7 (−0.46, 1.81; p = 0.239) and 2.1 (0.94, 3.32; p = 0.001) higher mean EDSS (with p = 0.0007 for the overall contribution of the categorical variable); and in the same model mean EDSS was predicted with borderline significance to be higher by 0.4 (95% CI 0.01, 0.78; p = 0.045) per category of the patient's most extensive lesion. In total 30 patients had three or more lesions that involved a lateral column and extended to the GM: RRMS n = 6, PPMS n = 10; and SPMS n = 14.
None of the other MRI variables entered additionally into this model (see supplementary Table 2 ) was significant, but in particular neither (i) the total number of lesions, nor (ii) the number of lesions involving a lateral column but not extending to GM, nor (iii) the number of lesions extending to GM but not involving a lateral column, contributed significantly to the above model, confirming the importance of the more specific predictor of lesions that both involved a lateral column and extended to GM.
The proportion of explained variance (R 2 ) was 66%, compared to 46% for a model with only age, gender and disease duration, and with 44% for a model with just the two lesion variables.
Discussion
In this study we demonstrate two new associations of spinal cord lesion characteristics with clinical status and disability in MS. Firstly, focal lesions involving at least two spinal cord WM columns and extending to the GM (Type II and IV lesions) are more frequent in SPMS. Secondly, focal lesions that involve lateral columns and extend to GM are independently associated with disability. We also confirmed previous observations in finding a significant association between diffuse abnormalities and progressive MS. [4] [5] [6] [7] Post-mortem spinal cord studies have demonstrated extensive focal lesions involving several WM columns and GM. 20, 21 However, due to inherent limitations of spinal cord imaging, 22 there has been little information on the anatomical location of focal lesions seen on axial in vivo images in progressive MS, and how those features compare with findings in the earlier relapsing-remitting phase of the disease.
Although some previous imaging studies demonstrated a greater number of focal lesions in SP than RRMS, 4, 5, 9, 23 our study extends these findings. Firstly, this was the first study to document a greater number of spinal cord columns covered by individual focal lesions in SPMS. This observation was in comparison to RRMS and CIS, in which focal lesions were more often restricted to a single column.
Secondly, we invariably detected extension to the GM when focal lesions were themselves more extensive (i.e. they involved at least two WM columns). Although we could not directly determine how much of the GM was affected by the lesions, our findings are consistent with spinal cord GM involvement being extensive in SPMS, and are in line with pathology reports, in which 56% and 67% of focal lesions involved the GM. 24, 25 Although the total number of lesions detected was greater in PPMS than RRMS, neither the number of lesions involving two or more WM columns nor extension to the GM differed significantly from RRMS. These results are in agreement with previous studies demonstrating similar focal spinal cord lesion abnormalities in both RRMS and PPMS. 3, 5, 23 The mechanisms that account for the greater number of lesions covering two or more WM columns in SPMS cannot be determined from this current study. However, this subgroup had disease duration of two decades, which may result in a more prolonged exposure to pathogenic processes that underlie the formation of new focal lesions, accounting in turn for the greater number of extensive lesions seen.
A question arising from this observation is whether lesions restricted to a single column of the cord evolve to encompass multiple columns. Extensive inflammation and demyelination 26 seen pathologically may provide a milieu conducive to the formation of new extensive lesions and/or coalescence of existing lesions. Longitudinal studies are required to elucidate the processes involved.
Diffuse abnormalities may be seen on sagittal PD-weighted images in MS and are more commonly seen in PPMS. [4] [5] [6] [7] [8] In this present study, people with progressive MS were almost six times more likely to have diffuse abnormalities compared to RRMS. Diffuse abnormalities may reflect demyelination and/ or axonal loss as reported at post-mortem. 5, 8 This current study demonstrates an independent association of disability with focal lesions that involve both the lateral column and extend to GM, which may reflect damage in the corticospinal tract, and/or GM inter-neuronal loss. 27 Recent studies have shown that both atrophy and microstructural abnormalities in cord GM are associated with disease progression in MS. 28, 29 The sequences used in our study could not differentiate lesional from non-lesional cord GM, and future studies are needed to identify image contrast modalities that enable depiction and quantitation of lesions within cord GM.
The independent association of the most extensive focal lesions with disability was only of borderline significance. This probably reflects several factors including limited pathological specificity of the imaging sequences employed, variable functional effects according to lesion location within the cord, and effects of remote lesions outside the cord region studied. In a recent report of a cohort with long disease duration MS, several MRI measures including lesions in the cervical cord and infratentorial regions were associated with disability. 30 A number of limitations should be considered in the interpretation of the results of this study. Firstly, the images were restricted to the upper cervical cord. This approach minimised physiological motion and likely provided the greatest yield of lesions. 20, 21 A future study would be of interest that employs axial sequences with greater coverage, 9 measures of cord atrophy 30 and quantitative MRI. 31 Although an association of cord atrophy and disability is well recognised, the sequences we used to detect lesions were not suited to investigate atrophy of the whole cord or GM or WM. Secondly, the extent of lesions within the cord GM could not be quantified, 24 nor was it possible to visualise subpial lesions, 20,21 therefore neither of these features could be incorporated into the classification system used. This may be improved in future studies using higher image resolution, modified spinal cord coil designs, and higher field strength imaging. 32 Finally, this cross-sectional study did not facilitate investigation of the progression of abnormalities, which could be addressed longitudinally.
Through the use of high-resolution axial cervical cord MRI, we have demonstrated significant associations of progressive MS and disability with focal cord lesion location and extent and with diffuse abnormalities. Future longitudinal studies are warranted to investigate the potential of cord lesion imaging to help understand and monitor MS disease progression.
